L322-0584 Screening compound: 2-(4-fluorophenoxy)-N-[6-(4-methoxybenzenesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]acetamide

L322-0584 Screening compound: 2-(4-fluorophenoxy)-N-[6-(4-methoxybenzenesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]acetamide
L322-0584 Screening compound: 2-(4-fluorophenoxy)-N-[6-(4-methoxybenzenesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L322-0584
2-(4-fluorophenoxy)-N-[6-(4-methoxybenzenesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L322-0584

Molecular Formula

C24H22FN3O6S (C24 H22 FN3 O6 S)

Compound Name

2-(4-fluorophenoxy)-N-[6-(4-methoxybenzenesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]acetamide

IUPAC name

2-(4-fluorophenoxy)-N-[6-(4-methoxybenzenesulfonyl)-13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]acetamide

SMILES

CN(c(c(N1C)c2)cc(NC(COc(cc3)ccc3F)=O)c2S(c(cc2)ccc2OC)(=O)=O)C1=O

InChI

InChI=1S/C24H22FN3O6S/c1-27-20-12-19(26-23(29)14-34-17-6-4-15(25)5-7-17)22(13-21(20)28(2)24(27)30)35(31,32)18-10-8-16(33-3)9-11-18/h4-13H,14H2,1-3H3,(H,26,29)

InChI Key

GKBRUFOAROHMEN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27245076

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.52

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.504

Distribution Coefficient, logD

3.503

Water Solubility, LogSw

-4.03

Polar Surface Area

84.647

Acid Dissociation Constant (pKa)

10.40

Base Dissociation Constant (pKb)

-3.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

L322-0584 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L322-0584 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L322-0584?
Check Price and Availability of L322-0584, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L322-0584 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L322-0584
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L322-0584
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L322-0584 available by request